C-1: THE FIRST INJECTION

As the human body must constantly differentiate between self and non-self cells, the first injection, C-1, contains proteins that must differentiate between damaged and healthy nerve cells.

Because the technology aims to assist individuals with a variety of health problems, the exact protein inserted into the capsules of C-1 is location and damage-specific. The correct diagnosis and specificity of the targeting protein in C-1 is important to prevent complications. If, for example, a more generalized protein were used, damaged cells in other parts of the body – ones that are a normal and healthy part of the cell life cycle – could be marked and could respond unpredictably to the second injection.

The primary component of C-1 needs to be highly specific and bind to only the damaged nerve cells which cause a serious problem, providing a sort of protein flag for the second injection.

The other component of the C-1 injection is the myelin-associated protein (MAG) antibody. In mature nerve cells, re-growth is inhibited by MAG, a glycoprotein found in the myelin surrounding the cell. Antibodies, by definition, destroy specific proteins or structures, in this case the inhibitor MAG. The destruction of the inhibitor proteins must be carefully regulated, however, in order to prevent the damage of normal nerve cells.

continue to second CONNECT injection